SCHEMBL23734261

SCHEMBL23734261

CC(C)(C)Cc1ccc2ccc(CC(C)(C)Cc3ccc(O)cc3)cc2c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 12/20 0.66
ESR2 Q92731 8/20 0.46
BLM P54132 1/20 0.41
THRA P10827 1/20 0.37
THRB P10828 1/20 0.37
SHBG P04278 2/20 0.35
ALOX5 P09917 1/20 0.35
ADRA2A P08913 2/20 0.34
ADORA3 P0DMS8 2/20 0.34
TACR2 P21452 2/20 0.34
SLC6A2 P23975 2/20 0.34
SLC6A4 P31645 2/20 0.34
SLC6A3 Q01959 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
HSPD1 P10809 1/20 0.34
ADRB3 P13945 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23734534 0.87 ESR1 (0.86) ESR1ESR2BLMTHRATHRB
SCHEMBL20642196 0.84 ESR1 (0.68) ESR1ESR2BLMTHRATHRB
SCHEMBL73405 0.81 ESR1 (1.00) ESR1ESR2BLMTHRATHRB
SCHEMBL24940008 0.80 MMP1 (0.43) ESR1SLC6A2SLC6A3KDM4ELMNA
SCHEMBL28092549 0.79 ESR1 (0.95) ESR1ESR2BLMTHRATHRB
SCHEMBL24517925 0.74 ESR1 (0.42) ESR1THRATHRBSLC6A2SLC6A4
SCHEMBL16383543 0.74 ESR1 (0.68) ESR1ESR2BLMSHBGSLC6A2
SCHEMBL19341333 0.74 CYP2A6 (0.59) ESR1ALDH1A1CYP3A4HTR2CHSD17B10
SCHEMBL22063921 0.72 ESR1 (0.58) ESR1ESR2SHBGSLC6A2SLC6A4
SCHEMBL19259341 0.72 ESR1 (0.65) ESR1ESR2BLMSHBGADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11084847-B2 Polyamide compound and use thereof SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2021-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11084847-B2 Polyamide compound and use thereof OPRK1, OPRM1, OPRD1 ESR1 1766/4885ESR2 1494/4885BLM 4861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.